← Open Payments lookup

CHRISTY FULLER: Open Payments

NPI 1346801883 · LINCOLN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$972 in 49 payments from 15 companies in 2025. Trend: 2023 $898 · 2024 $399 · 2025 $972

Food & beverage: $972
CompanyPaymentsAmount
ABBVIE INC.16$304
AstraZeneca Pharmaceuticals LP8$164
Novo Nordisk Inc7$132
Otsuka America Pharmaceutical, Inc.2$59
GlaxoSmithKline, LLC.2$53
Axsome Therapeutics, Inc.2$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$33
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Amgen Inc.2$31
Dexcom, Inc.1$25

Products named: VRAYLAR, AIRSUPRA, BOTOX, Ozempic, REXULTI, UBRELVY, TRELEGY ELLIPTA, BREZTRI.

Industry payments across AL — which companies pay providers there.